7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Hyperparathyroidism, Primary D049950 1 associated lipids
Breast Neoplasms, Male D018567 1 associated lipids
Severe Combined Immunodeficiency D016511 1 associated lipids
Peri-Implantitis D057873 1 associated lipids
Adrenocortical Adenoma D018246 1 associated lipids
Bone Demineralization, Pathologic D018488 1 associated lipids
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative D054438 1 associated lipids
Hashimoto Disease D050031 1 associated lipids
Legg-Calve-Perthes Disease D007873 1 associated lipids
Fluorosis, Dental D009050 1 associated lipids
Fibroma, Ossifying D018214 1 associated lipids
POEMS Syndrome D016878 1 associated lipids
Osteolysis, Essential D010015 1 associated lipids
Bone Cysts, Aneurysmal D017824 2 associated lipids
Bone Diseases, Developmental D001848 2 associated lipids
Actinomycosis D000196 2 associated lipids
Fractures, Stress D015775 2 associated lipids
Osteosclerosis D010026 2 associated lipids
Carcinoma, Neuroendocrine D018278 2 associated lipids
Osteophyte D054850 2 associated lipids
Lymphocytosis D008218 2 associated lipids
Prenatal Exposure Delayed Effects D011297 2 associated lipids
Pericardial Effusion D010490 2 associated lipids
Radicular Cyst D011842 2 associated lipids
Gingival Recession D005889 2 associated lipids
Carcinoma, Medullary D018276 2 associated lipids
Dengue D003715 2 associated lipids
Foot Deformities, Acquired D005531 2 associated lipids
Tooth Migration D014085 2 associated lipids
Musculoskeletal Diseases D009140 2 associated lipids
Hip Fractures D006620 2 associated lipids
No-Reflow Phenomenon D054318 2 associated lipids
Ossification, Heterotopic D009999 2 associated lipids
Adrenal Hyperplasia, Congenital D000312 2 associated lipids
Angina, Stable D060050 2 associated lipids
Sarcoma, Ewing D012512 2 associated lipids
Urologic Neoplasms D014571 2 associated lipids
Tooth Mobility D014086 2 associated lipids
Bacteroidaceae Infections D016866 2 associated lipids
Microvascular Angina D017566 2 associated lipids
Otosclerosis D010040 2 associated lipids
Root Resorption D012391 2 associated lipids
Dermatomyositis D003882 2 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Lithiasis D020347 2 associated lipids
Labyrinthitis D007762 2 associated lipids
Cholesteatoma, Middle Ear D018424 2 associated lipids
Eye Neoplasms D005134 2 associated lipids
Pasteurellaceae Infections D016871 2 associated lipids
Dental Pulp Calcification D003784 2 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Middleton K et al. Microfluidic co-culture platform for investigating osteocyte-osteoclast signalling during fluid shear stress mechanostimulation. 2017 J Biomech pmid:28552413
Lu LY et al. Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway. 2017 J. Orthop. Res. pmid:28248001
Kuroyanagi G et al. (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. 2017 Prostaglandins Other Lipid Mediat. pmid:28163121
Choi EM et al. Actein alleviates 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated cellular dysfunction in osteoblastic MC3T3-E1 cells. 2017 Environ. Toxicol. pmid:28836330
Ozaki Y et al. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis. 2017 PLoS ONE pmid:28937990
Tschiderer L et al. Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants. 2017 PLoS ONE pmid:28837646
Åšliwicka E et al. Serum irisin and myostatin levels after 2 weeks of high-altitude climbing. 2017 PLoS ONE pmid:28732027
Bergdolt S et al. Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing. 2017 PLoS ONE pmid:28614388
Spirlandeli AL et al. Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment. 2017 Clinics (Sao Paulo) pmid:28492723
Liu J et al. MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification. 2017 PLoS ONE pmid:28319142
Songia P et al. Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model. 2017 Oxid Med Cell Longev pmid:28261377
Jia J et al. Estrogen stimulates osteoprotegerin expression via the suppression of miR-145 expression in MG-63 cells. 2017 Mol Med Rep pmid:28260003
Shetelig C et al. Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function. 2017 PLoS ONE pmid:28253327
Irtyuga O et al. NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL. 2017 Biomed Res Int pmid:28246602
Hanmoto T et al. Effects of low-intensity pulsed ultrasound on osteoclasts: Analysis with goldfish scales as a model of bone. 2017 Biomed. Res. pmid:28239034
Fioramonti M et al. Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. 2017 Oncotarget pmid:28223547
Xiong L et al. Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. 2017 J. Cell Biol. pmid:28193701
Sponder M et al. Endurance training significantly increases serum endocan but not osteoprotegerin levels: a prospective observational study. 2017 BMC Cardiovasc Disord pmid:28056805
Hygum K et al. MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. 2017 Eur. J. Endocrinol. pmid:28049653
Dawson S and Lawrie A From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease. 2017 Pharmacol. Ther. pmid:27373854

Table of Content